IMRIS has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the new InVision 1.5 Surgical Theatre. This new InVision system further expands and complements the IMRIS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback